Financhill
Sell
45

OCSL Quote, Financials, Valuation and Earnings

Last price:
$15.26
Seasonality move :
-4.01%
Day range:
$15.15 - $15.30
52-week range:
$14.95 - $21.64
Dividend yield:
14.46%
P/E ratio:
21.13x
P/S ratio:
21.23x
P/B ratio:
0.84x
Volume:
924.4K
Avg. volume:
963.1K
1-year change:
-25.91%
Market cap:
$1.3B
Revenue:
$57.6M
EPS (TTM):
$0.72

Earnings Data

Next earnings date for OCSL
Jan 31
2025
Most recent earnings per share
$0.45
Missed by $0.11
(Nov 19/2024)
Consensus Estimate
$0.56
(Nov 19/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

OCSL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/31/2025 Q4 $91.8M -- -- $0.54 --
11/19/2024 Q3 $97.6M $36.5M $0.45 $0.56 -$0.11
08/01/2024 Q2 $99.4M -$922K $0.01 $0.56 -$0.55
04/30/2024 Q1 $99.6M $10.2M $0.12 $0.58 -$0.46
02/01/2024 Q4 $100.3M $11.8M $0.14 $0.61 -$0.47
11/14/2023 Q3 -- -- $0.62 $0.63 -$0.01
08/03/2023 Q2 -- -- $0.48 $0.63 -$0.15
05/04/2023 Q1 -- -- $0.29 $0.63 -$0.34
02/07/2023 Q4 -- -- $0.22 $0.61 -$0.39
11/15/2022 Q3 -- -- $0.21 $0.55 -$0.34
08/04/2022 Q2 -- -- -$0.62 $0.54 -$1.16
05/05/2022 Q1 -- -- $0.24 -- --
02/03/2022 Q4 -- -- $0.66 -- --
11/16/2021 Q3 -- -- $0.60 -- --
08/05/2021 Q2 -- -- $0.78 -- --
05/06/2021 Q1 -- -- $1.80 -- --
02/04/2021 Q4 -- -- $1.38 -- --
11/19/2020 Q3 -- -- $1.50 -- --
08/10/2020 Q2 -- -- $2.55 -- --
05/07/2020 Q1 -- -- -$3.51 -- --
02/06/2020 Q4 -- -- $0.30 -- --
11/20/2019 Q3 -- -- $0.30 -- --
08/07/2019 Q2 -- -- $0.42 -- --
05/08/2019 Q1 -- -- $1.38 -- --
02/07/2019 Q4 -- -- $0.60 -- --
11/29/2018 Q3 -- -- $0.72 -- --
08/08/2018 Q2 -- -- $0.51 -- --
05/08/2018 Q1 -- -- $0.42 -- --
02/08/2018 Q4 -- -- -$0.66 -- --
11/29/2017 Q3 -- -- -$2.67 -- --
08/09/2017 Q2 -- -- -$0.12 -- --
05/10/2017 Q1 -- -- $0.18 -- --
02/09/2017 Q4 -- -- -$1.56 -- --
09/30/2016 Q3 -- -- -$0.06 -- --
06/30/2016 Q2 -- -- -$0.12 -- --
03/31/2016 Q1 -- -- $0.09 -- --
12/31/2015 Q4 -- -- -$1.26 -- --
09/30/2015 Q3 -- -- -$0.06 -- --
06/30/2015 Q2 -- -- $0.39 -- --
03/31/2015 Q1 -- -- $0.51 -- --
12/31/2014 Q4 -- -- -$0.57 -- --

Oaktree Specialty Lending Earnings Questions

  • How Much did Oaktree Specialty Lending Generate in Revenue Last Quarter?

    Oaktree Specialty Lending reported $36.5M worth of top line sales in its most recent quarter.

  • Did Oaktree Specialty Lending Beat Earnings Last Quarter?

    Oaktree Specialty Lending announced earnings per share of $0.45 which represents a miss of analyst forecast a $0.56 per share.

  • Is Oaktree Specialty Lending Profitable?

    Oaktree Specialty Lending reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Oaktree Specialty Lending EPS Next Year?

    Oaktree Specialty Lending's earnings are forecast to grow from $0.72 per share to $2.23 per share next year representing an increase of 189.62%.

  • When is Oaktree Specialty Lending's Earnings Date?

    Oaktree Specialty Lending's next earnings date is January 31, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is down 6.68% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is down 1.14% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is down 3.16% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock